Navigation Links
Trubion Pharmaceuticals Provides Announcement Dates for Second Quarter and First Six Months Earnings Conference Call
Date:7/31/2008

SEATTLE, July 31 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced that it plans to issue earnings results for second quarter and first six months ended June 30, 2008, after the close of market on Aug. 7, 2008. The company's earnings conference call will take place Aug. 7, 2008, at 2 p.m. PDT (5 p.m. EDT).

Both live events will be available for viewing on Trubion's website at http://investors.trubion.com/events.cfm.

Second Quarter and First Six Months Earnings Conference Call: 2 p.m. PDT / 5 p.m. EDT, Aug. 7, 2008

Trubion will host a conference call and webcast to discuss its second quarter and six months 2008 financial results. The call will be held Aug. 7 at 2 p.m. Pacific time (5 p.m. Eastern time). The live event will be available from Trubion's website at http://investors.trubion.com/events.cfm, or by calling 1 (719) 325-4916 or 1 (877) 397-0292. A replay of the discussion will be available from Trubion's website or by calling 1 (719) 457-0820 or 1 (888) 203-1112 and entering 6969493. Replay will be available at 8 p.m. EDT until midnight, Aug. 14, 2008. The webcast replay will be available in the events section of Trubion's website.

About Trubion

Trubion is a biopharmaceutical company that is creating a pipeline of novel protein therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. The company's mission is to develop a variety of first-in-class and best-in-class product candidates, customized for optimal safety, efficacy, and convenience that it believes may offer improved patient experiences. Tr
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Trubion Announces Presentations at Upcoming Investor Conferences
2. Trubion Pharmaceuticals Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Dec. 1 Abrazo Media Relations-- T... ( http:// www.pedsorthopaedics.com ) located in M... surgeon Dr. J. Hunt Udall to its practice. ,,...paedic surgery after recently completing his fello...ssachusetts where he focused on adult and pediatri...
(Date:12/1/2009)...r 2009. Performing surgical operations without le...ome a reality. This is demonstrated by the recent ...e Transluminal Endoscopy Surgery), an innovative s... the body,s natural orifices. The results are all ...er hospital stay and faster recovery. Currently, t...
(Date:12/1/2009)... California are unable to successfully obtain info...s despite recent state legislation intended to imp... , Posing as low-income uninsured patients, rese...e-third of the hospitals they approached and the e...e allowed under California law, according to the f...
(Date:12/1/2009)... system tied to academic achievement, study finds ... strong cardiovascular system in young adulthood m...es and more overall success later in life, new res...aypeople know (or should know) the benefits of exe...s of a new study, appearing in this week,s online ...
(Date:12/1/2009)...xas, Dec. 1 For many employers, th...s more than just an employee benefit, it,s providi...by Lobby Stores, Inc. is leading this effort, with...th and wellness center at its corporate offices, b...s directly to employees and their dependents. ,...
Breaking Medicine News(10 mins):Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 3Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3
...ew policy that significantly limits interactions w...and appropriate partnerships with drug and medical...ne Policy on Interaction with Industry, the policy...tists, students and staff may interact with indust...
...stbands had much less nausea while receiving radia...addition to anti-nausea medication, according to a...om Management by University of Rochester Medical ...n might be why elastic wristbands reduce nausea. ...
...youth are engaging in sexual intercourse as early ...The University of Texas School of Public Health. ...ril issue of Journal of School Health . , Chris...middle school students in a large southeastern U.S...
...Individuals How Much They Will Pay for Treatment a...hcare , , ANN ARBOR, Mich., April 8 As people ta...s cost, employers and health insurers need better ... challenge, HealthEquity has embedded Consumer Adv...
...gislators brainstorm ways to reduce significant le...ness continues to find innovative solutions to edu... and abuse. Innocorp President Michael Aguilar ann...y Outreach and Education Services. , , "Impaired ...
... PHILADELPHIA, April 8 Kyle,s Treehouse -- an o...nounces their new initiative for Autism Awareness ... and inspiration. Autism151 focuses on the posit..., giving them even more reasons to hope. , , ...
Other Medicine News:Health News:New JHM policies tighten rules on industry interactions 2Health News:New JHM policies tighten rules on industry interactions 3Health News:Wristbands ease nausea with cancer treatment 2Health News:Middle school youth as young as 12 engaging in risky sexual activity 2Health News:HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions 2Health News:HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions 3Health News:Former MADD National President Joins Innocorp, ltd. 2Health News:Kyle's Treehouse Launches Autism151.com for Autism Awareness Month 2
(Date:11/30/2009)...v. 30 Nektar Therapeutic...f Lorianne Masuoka, M.D. to Senior Vice President ...t directly to Nektar,s President and Chief Executi...utstanding leadership and highly effective clinica... rapidly advancing Nektar,s proprietary clinical p...
(Date:11/30/2009)...wire/ -- Breast-Specific Gamma Imaging (BSGI) sign...t or high-risk lesions in patients with negative o...o results of a multicenter study presented today a...f North America (RSNA). ,, In this retrospectiv...ic imaging modality at four institutions and was c...
(Date:11/30/2009)...30 SCOLR Pharma, Inc. (N...25, 2009, the NYSE Amex LLC (the "Exchange") notif... plan to comply with its previously disclosed list...change Company Guide. Specifically, the deficienc...which were so substantial in relation to its overa...
Breaking Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Analysis Sheds Light on Proteins Role in Cancer 48086 1Fatty foods not empty stomach fire up hunger hormone 8733 1Fatty foods not empty stomach fire up hunger hormone 8733 2Code Red for the Health Care System 48083 1Code Red for the Health Care System 48083 2Code Red for the Health Care System 48083 3
...ceuticals, Inc. (Nasdaq: MAPP ) announced today ...nit Dose Budesonide (UDB) for the potential,treatm...d that the clinical,trial did not meet its co-prim...es from baseline in nighttime and daytime composit..., when compared with placebo. Median,nebulization...
...icals (Nasdaq: BCRX ) today announced that the f...peramivir in patients hospitalized for influenza w..., Dr. Michael G. Ison, Assistant Professor, Divisi...on at Northwestern University Feinberg School of...n Respiratory Viral Infections taking place in Ban...
Other Medicine Technology:MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 2MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints 3Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 2Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 3Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 4Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 5
...first 192 channel simultaneous sampling EEG with 6...e for routine EEG exam rooms as well as epilepsy c...nal analysis software for automatic spike and seiz...leep analysis. Quality Data Acquisition ,The Ne...
... purchase an XLTEK Mobee, you're getting an ambula...bee32 and the Mobee O2 can be used for ambulatory ...al in-lab EEG monitoring, or in-lab sleep studies....ll 10/20 electrode placement. The Mobee O2 include...
Vision Monitor Visual Electrophysiology: MonEl1
...30 Slit Lamp is an all-in-one instrument for obser...Its optimally structured design also allows the SL...hieved by the possibility of operating the slit pr...ft or right hand. The instrument configuration all...
Medicine Products: